Tag: leading-class
-
J&J psoriasis drug Stelara eases Crohn’s disease in second trial
Johnson & Johnson’s Stelara psoriasis drug has shown effectiveness against Crohn’s disease in a second late-stage trial, the company said on Friday, bolstering prospects of its approval for the additional use. The Phase 3 study showed Stelara induced remissions in moderate to severe Crohn’s disease patients who had previously failed to benefit from TNF inhibitors,…
-
Put meditation on the menu to boost weight loss success
When embarking on a diet, the focus is usually on healthy eating and exercise. Researchers from Vanderbilt University School of Medicine, USA, recently found mindfulness meditation beneficial to the prevention and treatment of obesity in children. A French NutriNet-Santé study from December 2015 revealed that regular meditation could reduce the risk of obesity by 50%.
-
Still uninsured for your Latin American event? Then expect a Zika exclusion
By Noor Zainab Hussain and Carolyn Cohn LONDON (Reuters) – Organizers of rock concerts and conferences in Latin America or fringe events at the Rio Olympics beware: if you still need insurance to cover cancellation due to the Zika virus, it's probably too late. It took out cancellation insurance for this August's games in the…
-
Brazil says confirmed and suspected microcephaly cases rise to 5,131
The number of confirmed and suspected cases of microcephaly in Brazil associated with the Zika virus has risen to 5,131 from 4,976 a week earlier, the Ministry of Health said on Friday. Of these, the number of confirmed cases climbed to 863 from 745 a week earlier, while suspected ones increased to 4,268 from 4,231…